These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 17372920

  • 1. The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy.
    Vicini FA, Antonucci JV, Goldstein N, Wallace M, Kestin L, Krauss D, Kunzmann J, Gilbert S, Schell S.
    Cancer; 2007 Apr 01; 109(7):1264-72. PubMed ID: 17372920
    [Abstract] [Full Text] [Related]

  • 2. Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: a molecular based clonality evaluation.
    McGrath S, Antonucci J, Goldstein N, Wallace M, Mitchell C, Grills I, Jolly S, Kestin L, Vicini F.
    Am J Clin Oncol; 2010 Feb 01; 33(1):17-22. PubMed ID: 19636236
    [Abstract] [Full Text] [Related]

  • 3. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors.
    Goldstein NS, Vicini FA, Hunter S, Odish E, Forbes S, Kraus D, Kestin LL.
    Am J Clin Pathol; 2005 May 01; 123(5):679-89. PubMed ID: 15981807
    [Abstract] [Full Text] [Related]

  • 4. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C, Kestin L, Go N, Krauss D, Chen P, Goldstein N, Martinez A, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2005 Dec 01; 63(5):1514-21. PubMed ID: 16005576
    [Abstract] [Full Text] [Related]

  • 5. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
    Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KK.
    Cancer; 2002 Nov 15; 95(10):2059-67. PubMed ID: 12412158
    [Abstract] [Full Text] [Related]

  • 6. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H, Vicini FA, Kestin LL, Goldstein NS, Decker D, Pettinga J, Ingold J, Benitez P, Neumann K, Rebner M, Dekhne N, Martinez A.
    Cancer; 2004 Aug 15; 101(4):713-20. PubMed ID: 15305400
    [Abstract] [Full Text] [Related]

  • 7. Long-term efficacy and patterns of failure after accelerated partial breast irradiation: a molecular assay-based clonality evaluation.
    Vicini FA, Antonucci JV, Wallace M, Gilbert S, Goldstein NS, Kestin L, Chen P, Kunzman J, Boike T, Benitez P, Martinez A.
    Int J Radiat Oncol Biol Phys; 2007 Jun 01; 68(2):341-6. PubMed ID: 17306933
    [Abstract] [Full Text] [Related]

  • 8. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam F.
    Cancer; 2005 Jul 01; 104(1):20-9. PubMed ID: 15912514
    [Abstract] [Full Text] [Related]

  • 9. Changes in temporal patterns of local failure after breast-conserving therapy and their prognostic implications.
    Krauss DJ, Kestin LL, Mitchell C, Martinez AA, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):731-40. PubMed ID: 15465189
    [Abstract] [Full Text] [Related]

  • 10. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK, Vicini FA, Wallace M, Mitchell C, Chen P, Ghilezan M, Gilbert S, Kunzman J, Benitez P, Martinez A.
    Int J Radiat Oncol Biol Phys; 2007 Sep 01; 69(1):32-40. PubMed ID: 17467920
    [Abstract] [Full Text] [Related]

  • 11. Molecular clonality relationships in initial carcinomas, ipsilateral breast failures, and distant metastases in patients treated with breast-conserving therapy: evidence suggesting that some distant metastases are derived from ipsilateral breast failures and that metastases can metastasize.
    Goldstein NS, Vicini FA, Hunter S, Odish E, Forbes S, Kestin LL.
    Am J Clin Pathol; 2005 Jul 01; 124(1):49-57. PubMed ID: 15923174
    [Abstract] [Full Text] [Related]

  • 12. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y, Akiyama F, Iino Y, Ikeda T, Akashi-Tanaka S, Ohsumi S, Kusama M, Sano M, Shin E, Suemasu K, Sonoo H, Taguchi T, Nishi T, Nishimura R, Haga S, Mise K, Kinoshita T, Murakami S, Yoshimoto M, Tsukuma H, Inaji H.
    Cancer; 2006 Jan 01; 106(1):35-41. PubMed ID: 16333848
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S, Kestin LL, Goldstein NS, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):365-71. PubMed ID: 16965988
    [Abstract] [Full Text] [Related]

  • 15. Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy.
    Zhou P, Gautam S, Recht A.
    Breast Cancer Res Treat; 2007 Jan 01; 101(1):51-7. PubMed ID: 16821084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ipsilateral breast tumor recurrence after breast-conserving therapy.
    Panet-Raymond V, Truong PT, Watson PH.
    Expert Rev Anticancer Ther; 2010 Aug 01; 10(8):1229-38. PubMed ID: 20735309
    [Abstract] [Full Text] [Related]

  • 18. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
    Antonucci JV, Wallace M, Goldstein NS, Kestin L, Chen P, Benitez P, Dekhne N, Martinez A, Vicini F.
    Int J Radiat Oncol Biol Phys; 2009 Jun 01; 74(2):447-52. PubMed ID: 19058921
    [Abstract] [Full Text] [Related]

  • 19. High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers.
    Bollet MA, Servant N, Neuvial P, Decraene C, Lebigot I, Meyniel JP, De Rycke Y, Savignoni A, Rigaill G, Hupé P, Fourquet A, Sigal-Zafrani B, Barillot E, Thiery JP.
    J Natl Cancer Inst; 2008 Jan 02; 100(1):48-58. PubMed ID: 18159071
    [Abstract] [Full Text] [Related]

  • 20. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.
    Shen J, Hunt KK, Mirza NQ, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Ross MI, Ames FC, Feig BW, Singletary SE, Cristofanilli M, Meric-Bernstam F.
    Cancer; 2005 Aug 01; 104(3):479-90. PubMed ID: 15968686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.